메뉴 건너뛰기




Volumn 28, Issue 7, 2009, Pages 835-840

The effectiveness and safety of mycophenolate mofetil in lupus nephritis

Author keywords

Lupus; Lupus nephritis; Mycophenolate; Mycophenolate mofetil; Renal lupus; Systemic lupus erythematosus

Indexed keywords

ALBUMIN; ANGIOTENSIN RECEPTOR ANTAGONIST; AZATHIOPRINE; CORTICOSTEROID; CREATININE; CYCLOPHOSPHAMIDE; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DNA ANTIBODY; HYDROXYCHLOROQUINE; METHOTREXATE; METHYLPREDNISOLONE; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; PREDNISONE;

EID: 67349222206     PISSN: 07703198     EISSN: None     Source Type: Journal    
DOI: 10.1007/s10067-009-1163-6     Document Type: Article
Times cited : (5)

References (8)
  • 2
    • 33847193118 scopus 로고    scopus 로고
    • Systematic review and meta-analysis of randomized trials and cohort studies of mycophenolate mofetil in lupus nephritis
    • Moore RA, Derry S (2006) Systematic review and meta-analysis of randomized trials and cohort studies of mycophenolate mofetil in lupus nephritis. Arthritis Res Ther 8:R182
    • (2006) Arthritis Res Ther , vol.8
    • Moore, R.A.1    Derry, S.2
  • 3
    • 1442355581 scopus 로고    scopus 로고
    • Sequential therapies for proliferative lupus nephritis
    • Contreras G, Pardo V, Leclercq B et al (2004) Sequential therapies for proliferative lupus nephritis. N Engl J Med 350:971-980
    • (2004) N Engl J Med , vol.350 , pp. 971-980
    • Contreras, G.1    Pardo, V.2    Leclercq, B.3
  • 4
    • 0031229830 scopus 로고    scopus 로고
    • Updating the American College of Rheumatology revised criteria for the classification of systemic lupus erythematosus [letter]
    • Hochberg MC (1997) Updating the American College of Rheumatology revised criteria for the classification of systemic lupus erythematosus [letter]. Arthritis Rheum 40:1725
    • (1997) Arthritis Rheum , vol.40 , pp. 1725
    • Hochberg, M.C.1
  • 5
    • 9244220686 scopus 로고    scopus 로고
    • Review of ACR renal criteria in systemic lupus erythematosus
    • Dooley MA, Aranow C, Ginzler EM (2004) Review of ACR renal criteria in systemic lupus erythematosus. Lupus 13(11):857-860
    • (2004) Lupus , vol.13 , Issue.11 , pp. 857-860
    • Dooley, M.A.1    Aranow, C.2    Ginzler, E.M.3
  • 6
    • 33646679637 scopus 로고    scopus 로고
    • Outcomes in African Americans and Hispanics with lupus nephritis
    • Contreras G, Lenz O, Pardo V et al (2006) Outcomes in African Americans and Hispanics with lupus nephritis. Kidney Int 69:1846
    • (2006) Kidney Int , vol.69 , pp. 1846
    • Contreras, G.1    Lenz, O.2    Pardo, V.3
  • 7
    • 0034687429 scopus 로고    scopus 로고
    • Efficacy of mycophenolate mofetil in patients with diffuse proliferative lupus nephritis
    • Hong Kong-Guangzhou Nephrology Study Group
    • Chan TM, Li FK, Tang CS et al (2000) Efficacy of mycophenolate mofetil in patients with diffuse proliferative lupus nephritis. Hong Kong-Guangzhou Nephrology Study Group. N Engl J Med 343:1156-1162
    • (2000) N Engl J Med , vol.343 , pp. 1156-1162
    • Chan, T.M.1    Li, F.K.2    Tang, C.S.3
  • 8
    • 20444466207 scopus 로고    scopus 로고
    • Long-term study of mycophenolate mofetil as continuous induction and maintenance treatment for diffuse proliferative lupus nephritis
    • Chan TM, Tse KC, Tang CSO, Mok MY, Li FK (2005) Long-term study of mycophenolate mofetil as continuous induction and maintenance treatment for diffuse proliferative lupus nephritis. J Am Soc Nephrol 16:1076-1084
    • (2005) J Am Soc Nephrol , vol.16 , pp. 1076-1084
    • Chan, T.M.1    Tse, K.C.2    Tang, C.S.O.3    Mok, M.Y.4    Li, F.K.5


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.